Combined treatment with Ginkgo biloba extract EGb 761 plus acetylcholinesterase inhibitors improved cognitive function and neuropsychiatric symptoms in patients with mild cognitive impairment

INTRODUCTION: Mild cognitive impairment (MCI) is a neurocognitive state between normal aging and dementia. There is currently no approved treatment for MCI, with acetylcholinesterase inhibitors (AChEI) being the commonly prescribed drugs. The Ginkgo biloba extract EGb 761 is an herbal remedy used fo...

Descripción completa

Detalles Bibliográficos
Autores principales: García‐Alberca, José María, Gris, Esther, Mendoza, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345397/
https://www.ncbi.nlm.nih.gov/pubmed/35929002
http://dx.doi.org/10.1002/trc2.12338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345397/
https://www.ncbi.nlm.nih.gov/pubmed/35929002
http://dx.doi.org/10.1002/trc2.12338

Ejemplares similares